What specific treatments were administered to the newborn with withdrawal symptoms?

Question

Accepted Answer

Newborn Shows No Withdrawal Symptoms After Treatment for Drug Exposure

A newborn girl, who tested positive for amphetamine and benzodiazepines shortly after birth, has shown no withdrawal symptoms following treatment, according to the Kelantan Health Department. Examinations using the Finnegan Score indicated the baby's score has reduced to zero. The department will continue to monitor the infant's development to identify any potential long-term effects on her mental, growth, and physical development.
Assessment of Withdrawal Symptoms

The baby underwent urine screening at the Neonatal Intensive Care Unit (NICU) of Hospital Raja Perempuan Zainab II, which revealed the presence of amphetamine and benzodiazepines. Following this, the infant was treated, and subsequent assessments using the Finnegan Score demonstrated a complete resolution of withdrawal symptoms, with the score now registering at zero. This score is a standardised tool used to assess the severity of neonatal abstinence syndrome, a condition that can occur when newborns are exposed to drugs or medications in the womb. A score of zero indicates the absence of observable withdrawal signs.
Cause of Neonatal Drug Exposure

Information gathered suggests the mother had consumed tranquilizers during her pregnancy. While the baby exhibited withdrawal symptoms, it is anticipated that these effects are unlikely to be prolonged. Neonatal drug withdrawal typically occurs when a fetus is exposed to substances like opioids, benzodiazepines, or certain antidepressants in utero. The severity and duration of these symptoms can vary widely depending on the type of substance, the dosage, and the duration of exposure.
Ongoing Monitoring and Intervention

The Kelantan Health Department has emphasised the importance of continuous monitoring to ensure any potential impacts on the baby's development are identified at an early stage. This proactive approach allows for timely intervention and support if any developmental concerns arise. The department's commitment to ongoing observation underscores the need for comprehensive care for infants exposed to substances prenatally, aiming to ensure their healthy growth and well-being.

Reading history

Hide →

This history is cleared when the page is closed.

What specific treatments were administered to the newborn with withdrawal symptoms?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

2

0

0

Share with friends